Laura S Gaeta

Title: Laura S. Gaeta: Innovator in Diabetes Treatment

Introduction

Laura S. Gaeta is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of diabetes treatment through her innovative research and development of pharmaceutical compositions. With a total of 3 patents, her work has had a profound impact on the management of insulin-requiring states.

Latest Patents

Among her latest patents are "Pramlintide pro H-amylin salts and compositions" and "Amylin agonist peptides and uses therefor." These patents focus on agonist analogues of amylin and related pharmaceutical compositions. They provide methods of treatment for diabetes and other insulin-requiring states, as well as methods for treating hypoglycemia.

Career Highlights

Laura has worked with notable companies such as Amylin Pharmaceuticals, Inc. and Amylin Corporation. Her experience in these organizations has allowed her to develop groundbreaking treatments that address critical health issues related to diabetes.

Collaborations

Throughout her career, Laura has collaborated with esteemed colleagues, including Elisabeth Albrecht and Howard Jones. These partnerships have fostered an environment of innovation and have contributed to her success as an inventor.

Conclusion

Laura S. Gaeta's contributions to diabetes treatment through her patents and collaborations highlight her role as a leading innovator in the pharmaceutical industry. Her work continues to influence the development of effective treatments for those living with diabetes.